Deficiency of WTAP in islet beta cells results in beta cell failure and diabetes in mice
Authors:
- 15 March 2023
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 66 (6) , 1084-1096
Abstract
Aims/hypothesis N6-methyladenosine (m6A) mRNA methylation and m6A-related proteins (methyltransferase-like 3 [METTL3], methyltransferase-like 14 [METTL14] and YTH domain containing 1 [YTHDC1]) have been shown to regulate islet beta cell function and the pathogenesis of diabetes. However, whether Wilms’ tumour 1-associating protein (WTAP), a key regulator of the m6A RNA methyltransferase complex, regulates islet beta cell failure during pathogenesis of diabetes is largely unknown. The present study aimed to investigate the role of WTAP in the regulation of islet beta cell failure and diabetes. Methods Islet beta cell-specific Wtap-knockout and beta cell-specific Mettl3-overexpressing mice were generated for this study. Blood glucose, glucose tolerance, serum insulin, glucose-stimulated insulin secretion (both in vivo and in vitro), insulin levels, glucagon levels and beta cell apoptosis were examined. RNA-seq and MeRIP-seq were performed, and the data were well analysed. Results WTAP was downregulated in islet beta cells in type 2 diabetes, due to lipotoxicity and chronic inflammation, and islet beta cell-specific deletion of Wtap (Wtap-betaKO) induced beta cell failure and diabetes. Wtap-betaKO mice showed severe hyperglycaemia (above 20 mmol/l [360 mg/dl]) from 8 weeks of age onwards. Mechanistically, WTAP deficiency decreased m6A mRNA modification and reduced the expression of islet beta cell-specific transcription factors and insulin secretion-related genes by reducing METTL3 protein levels. Islet beta cell-specific overexpression of Mettl3 partially reversed the abnormalities observed in Wtap-betaKO mice. Conclusions/interpretation WTAP plays a key role in maintaining beta cell function by regulating m6A mRNA modification depending on METTL3, and the downregulation of WTAP leads to beta cell failure and diabetes. Data availability The RNA-seq and MeRIP-seq datasets generated during the current study are available in the Gene Expression Omnibus database repository (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE215156; https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE215360). Graphical abstractKeywords
Funding Information
- National Natural Science Foundation of China (92057110 and 31971083)
This publication has 28 references indexed in Scilit:
- SH2B1 in β-Cells Regulates Glucose Metabolism by Promoting β-Cell Survival and Islet ExpansionDiabetes, 2014
- A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylationNature Chemical Biology, 2013
- Inflammation in Obesity and Diabetes: Islet Dysfunction and Therapeutic OpportunityCell Metabolism, 2013
- Nkx6.1 Controls a Gene Regulatory Network Required for Establishing and Maintaining Pancreatic Beta Cell IdentityPLOS Genetics, 2013
- Topology of the human and mouse m6A RNA methylomes revealed by m6A-seqNature, 2012
- Pancreatic β Cells Require NeuroD to Achieve and Maintain Functional MaturityCell Metabolism, 2010
- Foxa2 Controls Vesicle Docking and Insulin Secretion in Mature β CellsCell Metabolism, 2007
- MafA Is a Key Regulator of Glucose-Stimulated Insulin SecretionMolecular and Cellular Biology, 2005
- β-Cell Pdx1 Expression Is Essential for the Glucoregulatory, Proliferative, and Cytoprotective Actions of Glucagon-Like Peptide-1Diabetes, 2005
- Reduction in Pancreatic Transcription Factor PDX-1 Impairs Glucose-stimulated Insulin SecretionJournal of Biological Chemistry, 2002